SCHEMBL3963648

SCHEMBL3963648

CCCCc1nc2cc(C(F)(F)F)ccn2c(=O)c1-c1ccc(NC2CCN(C(=O)O)C2)cc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RHOC P08134 1/20 0.35
RHOA P61586 1/20 0.35
EPHX2 P34913 4/20 0.34
MCHR1 Q99705 4/20 0.34
PHGDH O43175 2/20 0.34
TRPC3 Q13507 1/20 0.34
TRPC7 Q9HCX4 1/20 0.34
CYP2D6 P10635 1/20 0.34
TEAD1 P28347 2/20 0.33
KMT2A Q03164 1/20 0.33
MLNR O43193 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
SPR P35270 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3R1 P27986 1/20 0.32
GFER P55789 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5132406 0.91 SCN9A (0.41) MAPK1HTTPIK3CD
SCHEMBL5132408 0.91 SCN9A (0.41) MAPK1HTTPIK3CD
SCHEMBL3961800 0.86 AGTR1 (0.43) KMT2ASPRGFER
SCHEMBL3957995 0.83 IDH2 (0.39)
SCHEMBL3957991 0.83 IDH2 (0.39)
Hydrochloric Acid SCHEMBL3959461 0.83 IDH2 (0.39)
SCHEMBL3955073 0.83 ENPP2 (0.36) MCHR1KMT2AMLNRGFER
Hydrochloric Acid SCHEMBL5132301 0.83 IDH2 (0.39)
SCHEMBL3962925 0.82 KDM4E (0.36) EPHX2GFER
SCHEMBL3961045 0.81 GFER (0.49) KMT2AGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079737-A1 PYRIDOPYRIMIDINONE COMPOUNDS USEFUL IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2009-07-22 EP disclosed
WO-2008097991-A1 PYRIDOPYRIMIDINONE COMPOUNDS USEFUL IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-14 WO disclosed